Some thoughts on Cynata Therapeutics

As a funds manager, I wouldn't touch Cynata Therapeutics with a barge pole.

The reason is really simple. No one has any idea what the company is worth. It could be worth nothing, or it could be worth $30 a share in five years time. We just don't know. There is too much risk.

If you are investing money for other people, you have to have some defensible reason for paying a certain price for a stock and you have to be responsible with the level of risk you take. So most managers except, for a few industry specialists, will ignore CYP.


As a private investor, I have owned Cynata Therapeutics since before it became Cynata Therapeutics. I only have to explain it to my wife.